{
    "fund_name": "Amundi ShortDAX Daily (-2x) Inverse UCITS ETF Acc",
    "type": "ETF",
    "ucits": true,
    "replication_method": "synthetic",
    "leverage": true,
    "inverse": true,
    "derivatives": true,
    "swaps": true,
    "complex_factors": [
        "Inverse exposure with -2x daily leverage",
        "Synthetic replication using OTC swaps",
        "Counterparty risk from swap agreements",
        "Complex index tracking (ShortDAX x2)",
        "Potential for performance divergence due to daily rebalancing"
    ],
    "classification": "complex",
    "supporting_data": "The ETF is classified as complex under MiFID II due to several key factors: 1) It uses synthetic replication with OTC swaps, exposing investors to counterparty risk; 2) It employs inverse leverage (-2x) which creates non-linear risk profiles; 3) The daily rebalancing mechanism means performance may diverge significantly from simple inverse performance over time; 4) The underlying index (ShortDAX x2) is itself complex, combining inverse exposure with leverage; 5) The KIID explicitly warns about the fund's complexity and suitability for retail investors. While the fund is UCITS-compliant and has relatively low ongoing charges (0.60%), these structural features make it unsuitable for retail investors without specialized knowledge. The PRIIPs KID and factsheet confirm the extensive use of derivatives and the complex nature of the tracking strategy.",
    "confidence": 95,
    "counter_argument": "One might argue that since the fund is UCITS-compliant and has a relatively simple fee structure, it should be considered non-complex. However, the extensive use of derivatives for leverage and inverse exposure, combined with the daily rebalancing mechanism that can lead to performance divergence, clearly makes this a complex product under MiFID II standards. The explicit warnings in the documentation about suitability for retail investors further support this classification."
}